We came across a bullish thesis on Innoviva, Inc on Deep-Value Stocks’s Substack. In this article, we will summarize the bulls’ thesis on INVA. Innoviva, Inc’s share was trading at $22.48 as of February 11th. INVA’s trailing and forward P/E were 13.54 and 10.83 respectively according to Yahoo Finance.
Cherries/Shutterstock.com
Innoviva, Inc. engages in the development and commercialization of pharmaceutical products in the United States and internationally. INVA presents a...
